|
|
|
Insider
Information: |
Sherwin Stephen A |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
190,305 |
|
Indirect Shares
|
2,500 |
|
|
Direct
Value |
$15,231,079 |
|
|
Indirect Value
|
$29,700 |
|
|
Total
Shares |
192,805 |
|
|
Total
Value |
$15,260,779 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-05-17 |
26,504 |
2004-09-22 |
0 |
Premium* |
|
ANI Pharmaceuticals Inc |
ANIP |
Director |
2009-10-14 |
86,760 |
2009-10-14 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
Director |
2023-06-26 |
18,738 |
2010-03-22 |
0 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
Director |
2015-05-21 |
22,003 |
2013-05-23 |
0 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2014-12-26 |
0 |
2014-12-26 |
2,500 |
Premium* |
|
Chinook Therapeutics Inc |
KDNY |
Director |
2015-06-25 |
36,300 |
|
0 |
Premium* |
|
Neon Therapeutics, Inc. |
NTGN |
Director |
2020-05-06 |
0 |
2020-05-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
Director |
|
2020-04-28 |
4 |
AS |
$99.39 |
$1,757,966 |
D/D |
(17,687) |
29,861 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2020-12-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,806 |
27,055 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2021-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
25,055 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2022-01-24 |
4 |
AS |
$74.43 |
$1,116,378 |
D/D |
(15,000) |
25,055 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2022-01-24 |
4 |
OE |
$6.66 |
$99,900 |
D/D |
15,000 |
40,055 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2023-01-03 |
4 |
OE |
$12.71 |
$385,350 |
D/D |
30,000 |
40,055 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2023-01-03 |
4 |
AS |
$118.85 |
$3,565,728 |
D/D |
(30,000) |
25,055 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2023-11-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,750 |
22,305 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2024-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,199 |
26,504 |
0 |
- |
|
NTGN |
Neon Therapeutics, Inc. |
Director |
|
2020-05-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(45,000) |
0 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Director |
|
2014-12-26 |
4 |
B |
$8.56 |
$21,395 |
I/I |
2,500 |
2,500 |
2.1 |
- |
|
61 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|